Gupta M - Search Results

1

Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort study.

Gupta M, Stukalin I, Meyers DE, Heng DYC, Monzon J, Cheng T, Navani V. Gupta M, et al. Front Oncol. 2024 May 31;14:1385425. doi: 10.3389/fonc.2024.1385425. eCollection 2024. Front Oncol. 2024. PMID: 38884085 Free PMC article.

2

Trends in health care spending on kidney cancer in the United States, 1996-2016.

Takemura K, Ahmed NS, Stukalin I, Gupta M, Ma C, Heng DYC. Takemura K, et al. Among authors: gupta m. Cancer. 2023 Jul 15;129(14):2161-2168. doi: 10.1002/cncr.34770. Epub 2023 Apr 2. Cancer. 2023. PMID: 37005866 Free article.

3

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.

Stukalin I, Navani V, Gupta M, Ruan Y, Boyne DJ, O'Sullivan DE, Meyers DE, Goutam S, Sander M, Ewanchuk BW, Brenner DR, Suo A, Cheung WY, Heng DYC, Monzon JG, Cheng T. Stukalin I, et al. Among authors: gupta m. Oncologist. 2023 Sep 7;28(9):812-822. doi: 10.1093/oncolo/oyad073. Oncologist. 2023. PMID: 37011230 Free PMC article.

4

Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma.

Gupta M, Stukalin I, Meyers D, Goutam S, Heng DYC, Cheng T, Monzon J, Navani V. Gupta M, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2319607. doi: 10.1001/jamanetworkopen.2023.19607. JAMA Netw Open. 2023. PMID: 37351883 Free PMC article.

5

Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors.

Samnani S, Sachedina F, Gupta M, Guo E, Navani V. Samnani S, et al. Among authors: gupta m. Cancer Drug Resist. 2023 Jun 27;6(2):416-429. doi: 10.20517/cdr.2023.02. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37457122 Free PMC article. Review.

6

Healthcare spending versus mortality in central nervous system cancer: Has anything changed?

Guo E, Gupta M, Rossong H, Boone L, Manoranjan B, Ahmed S, Stukalin I, Lama S, Sutherland GR. Guo E, et al. Among authors: gupta m. Neurooncol Pract. 2024 Apr 27;11(5):566-574. doi: 10.1093/nop/npae039. eCollection 2024 Oct. Neurooncol Pract. 2024. PMID: 39279779 Free article.

7

Brief Report: Trends in Incidence, Mortality, and Disability-Adjusted Life Years for Early-Onset Colorectal Cancer in Canada Between 1990 and 2019.

Stukalin I, Gupta M, Buhler K, Forbes N, Heitman SJ, Ma C. Stukalin I, et al. Among authors: gupta m. Curr Oncol. 2024 Dec 4;31(12):7765-7769. doi: 10.3390/curroncol31120571. Curr Oncol. 2024. PMID: 39727694 Free PMC article.

8

Colchicine Myopathy: A Case Series Including Muscle MRI and ABCB1 Polymorphism Data.

Gupta M, Nikolic A, Ng D, Martens K, Ebadi H, Chhibber S, Pfeffer G. Gupta M, et al. Front Neurol. 2019 May 24;10:553. doi: 10.3389/fneur.2019.00553. eCollection 2019. Front Neurol. 2019. PMID: 31178824 Free PMC article.

9

Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis.

Orton SM, Sangha A, Gupta M, Martens K, Metz LM, de Koning APJ, Pfeffer G. Orton SM, et al. Among authors: gupta m. Front Neurol. 2022 Dec 28;13:1064008. doi: 10.3389/fneur.2022.1064008. eCollection 2022. Front Neurol. 2022. PMID: 36644209 Free PMC article.

10

Development and validation of a 21-gene prognostic signature in neuroblastoma.

Gupta M, Kannappan S, Jain M, Douglass D, Shah R, Bose P, Narendran A. Gupta M, et al. Sci Rep. 2023 Aug 2;13(1):12526. doi: 10.1038/s41598-023-37714-9. Sci Rep. 2023. PMID: 37532697 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,276 results

Search Page

Filters